Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CES1 Mutations and Oseltamivir Metabolism Study
NCT01443806Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Jul 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oseltamivir in influenza, sponsored by University of Oxford. Primary endpoint: Time to maximum concentration at 4 hours. Started Jul 2011; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01443806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01443806.